Kymera Therapeutics Inc.
KYMR | NASDAQ
$121.23
+$3.56 (+3.03%)
Sep 22, 2026, 11:03 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -61.21M | -69.23M | -86.98M | -82.18M | -76.61M | -65.58M | -70.75M | -62.49M | -42.06M | -48.56M | -14.37M | -52.87M | -38.8M | -40.93M | -34.87M | -43M | -40.26M | -36.68M | -33.9M | -28.58M | -24.66M | -13.08M |
Depreciation & Amortization | 2.03M | 2.02M | 2.03M | 2.15M | 2.08M | 2.05M | 1.99M | 1.99M | 1.94M | 1.46M | 891K | 895K | 900K | 879K | 818K | 767K | 705K | 687K | 689K | 671K | 552K | 485K |
Stock-Based Compensation | 18.94M | 16.01M | 14.45M | 15.8M | 15.42M | 14.23M | 13.8M | 14.9M | 14.34M | 11.97M | 10.9M | 11.66M | 11.18M | 9.39M | 8.91M | 9.08M | 9.62M | 7.87M | 8.68M | 7.4M | 5.73M | 3.17M |
Other Working Capital | -26.06M | -43.73M | 7.28M | -1.52M | 25.48M | -12.19M | 3.03M | 975K | 10.46M | -14.87M | 14.47M | 9.47M | 8.8M | -7.27M | 1.83M | 1.96M | 928K | -10.78M | -16.61M | -14.83M | -14.05M | -18.53M |
Other Non-Cash Items | 32.61M | -2.73M | -2.04M | -1.36M | -2.12M | -2.53M | -10.22M | -5.96M | -27.94M | -6.33M | 11.14M | -1.15M | -16.54M | -5.25M | -16.58M | -2.56M | -8.88M | 1.18M | 1.64M | 1.68M | 1.23M | 1.28M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -46.44M | -34.91M | 5.79M | 38.48M | 1.35M | -27.33M | 3.4M | 1.36M | 10.78M | 1.87M | -516K | 9.82M | 8M | -8.05M | 2.18M | 1.45M | -178K | -13.35M | -15.46M | -18.42M | -13.36M | -14.68M |
Operating Cash Flow | -54.07M | -88.84M | -66.75M | -27.11M | -59.88M | -79.15M | -61.78M | -50.19M | -42.94M | -39.59M | 8.05M | -31.65M | -35.26M | -43.97M | -39.54M | -34.27M | -38.99M | -40.3M | -38.35M | -37.26M | -30.51M | -22.82M |
Capital Expenditures | -473K | -434K | -106K | -181K | -695K | -467K | -936K | 189K | -4.69M | -7.4M | -11.63M | -8.08M | -10.77M | -4.01M | -373K | -1.25M | -735K | -482K | -501K | -306K | -626K | -164K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.18M | 5.81M | n/a | n/a | 1.28M |
Purchase of Investments | -114.66M | -276.27M | -498.16M | n/a | -58.25M | -83.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -80.12M | -164.4M | -245.84M | -30.15M | -16.01M |
Sales Maturities Of Investments | 135.17M | 131.13M | 101.83M | n/a | 116.85M | 130.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 106.46M | 96.88M | 109.29M | 91.5M | 60.5M |
Other Investing Acitivies | n/a | 2.73M | 2.05M | -235.12M | 2.12M | 2.53M | 69.5M | -157.87M | 20.33M | -323.21M | 30.58M | 68.59M | 46.61M | 28.59M | -49.29M | -36.24M | 82.54M | -1.18M | -5.81M | n/a | n/a | -1.28M |
Investing Cash Flow | 20.05M | -142.84M | -394.4M | -235.3M | 60.02M | 48.62M | 68.57M | -157.68M | 15.64M | -330.61M | 18.95M | 60.51M | 35.84M | 24.58M | -49.67M | -37.48M | 81.8M | 25.86M | -68.02M | -136.86M | 60.72M | 44.32M |
Debt Repayment | n/a | -425K | -416K | -419K | -382K | -277K | -293K | -641K | -352K | -290K | 925K | -340K | -334K | -327K | -305K | -292K | -269K | -264K | -156K | -352K | -186K | -155K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -436K | n/a | n/a | 39.93M | n/a | n/a | 3.06M | 251.56M | 1.76M | 354.05M | 1.01M | 134K | 1.64M | 1.49M | 2.26M | 150.79M | 633K | 449K | 2.24M | 246.39M | 1.78M | 750K |
Financial Cash Flow | 14.42M | 18.77M | 705.22M | 39.51M | 245.73M | 258K | 2.77M | 250.92M | 1.41M | 353.76M | 1.93M | -206K | 1.31M | 1.16M | 1.95M | 150.5M | 364K | 185K | 2.05M | 246.04M | 1.59M | 595K |
Net Cash Flow | -19.6M | -212.91M | 244.07M | -222.9M | 245.86M | -30.28M | 9.55M | 43.05M | -25.88M | -16.44M | 28.93M | 28.66M | 1.89M | -18.23M | -87.25M | 78.75M | 43.18M | -14.25M | -104.32M | 71.92M | 31.8M | 22.1M |
Free Cash Flow | -54.54M | -89.27M | -66.85M | -27.29M | -60.58M | -79.62M | -62.72M | -50M | -47.63M | -46.99M | -3.58M | -39.72M | -46.02M | -47.98M | -39.91M | -35.52M | -39.72M | -40.78M | -38.85M | -37.57M | -31.14M | -22.99M |
Adj. Free Cash Flow | -73.48M | -105.28M | -81.31M | -43.09M | -76M | -93.85M | -76.52M | -64.91M | -61.97M | -58.96M | -14.48M | -51.38M | -57.21M | -57.36M | -48.82M | -44.59M | -49.34M | -48.65M | -47.53M | -44.96M | -36.86M | -26.16M |
Maintenance CapEx | -473K | -434K | -106K | -181K | -695K | n/a | -936K | 189K | n/a | -6.57M | n/a | -8.08M | -6.74M | -4.01M | n/a | -1.25M | -735K | -482K | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -467K | n/a | n/a | -4.69M | -836.16K | -11.63M | n/a | -4.03M | n/a | -373K | n/a | n/a | n/a | -501K | -306K | -626K | -164K |
Owner Earnings | -54.54M | -89.27M | -66.85M | -27.29M | -60.58M | -79.15M | -62.72M | -50M | -42.94M | -46.16M | 8.05M | -39.72M | -41.99M | -47.98M | -39.54M | -35.52M | -39.72M | -40.78M | -38.35M | -37.26M | -30.51M | -22.82M |
Add to Watchlist
Select watchlists to add or remove KYMR